186
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Study of the Diffusion Tensor Imaging for Preclinical Therapeutic Efficacy of Umbilical Cord Mesenchymal Stem Cell Transplantation in the Treatment of Spinal Cord Injury

, , , , &
Pages 9721-9732 | Published online: 13 Dec 2021

References

  • Wu QC, Zhang Y, Zhang WX, et al. Advance in riluzole for spinal cord injury (review). Chin J Rehabil Theory Pract. 2018;24(06):650–653.
  • Du SC, Zhang W, Hu HR, et al. Advances in the use of hypothermia in the treatment of spinal cord injuries. Prog Mod Biomed. 2017;17(11):2194–2196+2177.
  • Fu CG, Zhao HW, He LJ, et al. New advances in the treatment of spinal cord injury with galactagglutinin 1. Hainan Med J. 2015;26(16):2405–2406.
  • Li HM, Shen CL. Research advances in stem cell therapy for spinal cord injury. Acta Universitatis Medicinalis Anhui. 2019;54(04):663–666.
  • Levi AD, Anderson KD, Okonkwo DO, et al. Clinical outcomes from a Multi-Center Study of human neural stem cell transplantation in chronic cervical spinal cord injury. J Neurotrauma. 2019;36(6):891–902. doi:10.1089/neu.2018.5843
  • Silvestro S, Bramanti P, Trubiani O, Mazzon E. Stem cells therapy for spinal cord injury: an overview of clinical trials. Int J Mol Sci. 2020;21(2):659. doi:10.3390/ijms21020659
  • Facon D, Ozanne A, Fillard P, et al. MR diffusion tensor imaging and fiber tracking in spinal cord compression. AJNR. 2005;26:1587–1594.
  • Li CT, Pei L, Sun Y, Hou K, Jf Q. Quality control of magnetic resonance diffusion tensor imaging. Chin J Med Phys. 2020;37(01):69–74.
  • Shroff G, Dhanda Titus J, Shroff R. A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy. Am J Stem Cells. 2017;6(1):1–12.
  • Xu J, Zheng J, Cao YH, et al. Experimental study on transplantation of embryonic stem cells in treating spinal cord injury. China Trop Med. 2015;15(09):1031–1036.
  • Pereira IM, Marote A, Salgado AJ, Silva NA. Filling the gap: neural stem cells as a promising therapy for spinal cord injury. Pharmaceuticals. 2019;12(2):65. doi:10.3390/ph12020065
  • Gao JW, Guo HY, Lv XG, et al. Experimental effect of human umbilical cord mesenchymal stem cell transplantation on acute spinal cord injury repair. J Taishan Med Coll. 2018;39(12):1350–1353.
  • Salewski RP, Mitchell RA, Li L, et al. Transplantation of induced pluripotent stem cell-derived neural stem cells mediate functional recovery following thoracic spinal cord injury through remyelination of axons. Stem Cells Transl Med. 2015;4(7):743–754. doi:10.5966/sctm.2014-0236
  • Nazm Bojnordi M, Movahedin M, Tiraihi T, et al. Oligoprogenitor cells derived from spermatogonia stem cells improve remyelination in demyelination model. Mol Biotechnol. 2014;56(5):387–393. doi:10.1007/s12033-013-9722-0
  • Zheng G, Ge M, Qiu G, et al. Mesenchymal stromal cells affect disease outcomes via macrophage polarization. Stem Cells Int. 2017;20(15):47–53.
  • Zhang J, Cui Z, Feng G, et al. Rbm5 and p53 expression after rat spinal cord injury: implications for neuronal apoptosis. Int J Biochem Cell Biol. 2015;60:43–52. doi:10.1016/j.biocel.2014.12.020
  • Cofano F, Boido M, Monticelli M, et al. Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy. Int J Mol Sci. 2019;20(11):2698. PMID: 31159345; PMCID: PMC6600381. doi:10.3390/ijms20112698
  • Liau LL, Looi QH, Chia WC, Subramaniam T, Ng MH, Law JX. Treatment of spinal cord injury with mesenchymal stem cells. Cell Biosci. 2020;10(1):112. doi:10.1186/s13578-020-00475-3
  • Dasari VR, Veeravalli KK, Dinh DH. Mesenchymal stem cells in the treatment of spinal cord injuries: a review. World J Stem Cells. 2014;6(2):120–133. doi:10.4252/wjsc.v6.i2.120
  • Caron I, Rossi F, Papa S, et al. A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury. Biomaterials. 2016;75:135–147. doi:10.1016/j.biomaterials.2015.10.024
  • Kao CH, Chen SH, Chio CC, et al. Human umbilical cord blood-derived CD34+cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors. Shock. 2008;29(1):49–55. doi:10.1097/shk.0b013e31805cddce
  • Honmou O, Houkin K, Matsunaga T, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain. 2011;134(Pt 6):1790–1807. doi:10.1093/brain/awr063
  • Cl L, Wu Y. Advances of stem cells transplantation for spinal cord injury. Chin J Tissue Eng Res. 2011;15(32):6051–6054.
  • Dedeepiya V, Manjunath S, Murugan P, et al. Autologous bone marrow stem cells in spinal cord injury; our experience in clinical studies, animal studies, obstacles faced and steps for future. J Stem Cells Regen Med. 2010;6(3):177–179.
  • Libro R, Bramanti P, Mazzon E. The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration. Exp Ther Med. 2017;14(4):3355–3368. doi:10.3892/etm.2017.4939
  • Kwon HG, Su MS, Jang SH. Development of the transcallosal motor fiber from the corticospinal tract in the human brain: diffusion tensor imaging study. Front Hum Neurosci. 2014;8(8):153. doi:10.3389/fnhum.2014.00153
  • Zhan J, Zhang TJ, Yu CY, et al. The combination of diffusion tensor tractography and fractional anisotropy in evaluating the type of damage on corticospinal tracts due to intracerebral hemorrhage in the basal ganglia. J Clin Radiol. 2016;35:1320–1325.